In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

Clarins Super Restorative Serum Debuts With Brand’s Highest Price Point

This article was originally published in The Rose Sheet

  • News
  • The Rose Sheet

Executive Summary

Clarins Super Restorative Serum is bowing this fall priced at $110, representing a significant premium to the brand's existing skin care products

You may also be interested in...



Clarins Adds “Shimmering” Pastels To Its Color Story For Spring 2007

Clarins has retooled its color cosmetics line for spring, focusing on "highlighting and enhancing, enchanting and savoring beauty," the French cosmetics firm says

Clarins Adds “Shimmering” Pastels To Its Color Story For Spring 2007

Clarins has retooled its color cosmetics line for spring, focusing on "highlighting and enhancing, enchanting and savoring beauty," the French cosmetics firm says

Clarins Freshens Up Super Restorative With Eye Concentrate, Cream

Clarins is expanding its Super Restorative franchise in January with Total Eye Concentrate and Day Cream SPF 20, the French firm said

Table

View full table

Tags:
Latest Headlines

As Casgevy, Lyfgenia Launches Proceed, CRISPR And bluebird bio CEOs Reassure

South Korea Sees Pharma Leadership Transition

FDA-EMA Advice Pilot For Complex Generics: What Does Industry Have To Say?

The Sustainability Stakes Are Rising: ‘We Cannot Recycle Our Way Out Of This’

See All
UsernamePublicRestriction

Register

RS011279

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By